(Q36690297)

15 August 2017

1 reference

title

Long-term protection in children with meningococcal C conjugate vaccination: lessons learned (English)

1 reference

15 August 2017

1 reference

1

Ray Borrow

1 reference

15 August 2017

2

Elizabeth Miller

1 reference

15 August 2017

1 December 2006

1 reference

Expert Review of Vaccines

15 August 2017

1 reference

15 August 2017

5

1 reference

15 August 2017

6

1 reference

15 August 2017

851-857

1 reference

Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger

15 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Azithromycin-induced rash in infectious mononucleosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Human immunity to the meningococcus. I. The role of humoral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Human immunity to the meningococcus. II. Development of natural immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Priming for immunologic memory in adults by meningococcal group C conjugate vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Kinetics of booster responses to Haemophilus influenzae type B conjugate after combined diphtheria-tetanus-acelluar pertussis-Haemophilus influenzae type b vaccination in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Modeling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Can successful vaccines teach us how to induce efficient protective immune responses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Imperfect memory and the development of Haemophilus influenzae type B disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

John Henry Rolland Ramsay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Meningococcal conjugate vaccines: new opportunities and new challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

Effectiveness Analyses May Underestimate Protection of Infants after Group C Meningococcal Immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.851

21 January 2018

Identifiers

DOI

10.1586/14760584.5.6.851

1 reference

15 August 2017

1 reference

PubMed ID

17184222